Pharmacolog Reports Divestment of its Druglog to RaySearch Laboratories
Shots:
- Pharmacolog has divested its product line, Druglog, to RaySearch Laboratories for an aggregate of ~$0.81M which includes a cash consideration of $0.67M to be paid during the closure
- Through the divestment, RaySearch gains full ownership of DrugLog for its use in the field of oncology such as the measuring device, calibration parameters, source code and IP rights
- DrugLog is a cost-effective way to confirm the identity and concentration of compounded injectable drugs used with CT for cancer treatment. Its measuring device ensures the proper concentration of the right drug in the cytostatic compound
Ref: Pharmacolog | Image: Pharmacolog
Related News:- EpitoMAP, Animal Allergy Clinical Laboratories (AACL) & Kogyo Entered into a Collaboration and License Agreement to develop CRE-DR-B
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Shivani is a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
